The effects of flavoxate hydrochloride on voltage-dependent L-type Ca2+ currents in human urinary bladder

Br J Pharmacol. 2005 Sep;146(1):25-32. doi: 10.1038/sj.bjp.0706284.

Abstract

The effects of flavoxate hydrochloride (Bladderon, piperidinoethyl-3-methylflavone-8-carboxylate; hereafter referred as flavoxate) on voltage-dependent nifedipine-sensitive inward Ba(2+) currents in human detrusor myocytes were investigated using a conventional whole-cell patch-clamp. Tension measurement was also performed to study the effects of flavoxate on K(+)-induced contraction in human urinary bladder. Flavoxate caused a concentration-dependent reduction of the K(+)-induced contraction of human urinary bladder. In human detrusor myocytes, flavoxate inhibited the peak amplitude of voltage-dependent nifedipine-sensitive inward Ba(2+) currents in a voltage- and concentration-dependent manner (K(i) = 10 microM), and shifted the steady-state inactivation curve of Ba(2+) currents to the left at a holding potential of -90 mV. Immunohistochemical studies indicated the presence of the alpha(1C) subunit protein, which is a constituent of human L-type Ca(2+) channels (Ca(V)1.2), in the bundles of human detrusor smooth muscle. These results suggest that flavoxate caused muscle relaxation through the inhibition of L-type Ca(2+) channels in human detrusor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Barium / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / drug effects*
  • Calcium Channels, L-Type / physiology
  • Flavoxate / pharmacology*
  • Humans
  • In Vitro Techniques
  • Membrane Potentials / drug effects
  • Middle Aged
  • Muscle Contraction / drug effects
  • Muscle Relaxation / drug effects*
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / physiology
  • Parasympatholytics / pharmacology
  • Potassium / pharmacology
  • Urinary Bladder / drug effects*
  • Urinary Bladder / physiology

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Parasympatholytics
  • Barium
  • Flavoxate
  • Potassium